AKT1 and neoplasm: Another study identified the lumican/EGFR/AKT/HIF1 α signaling pathway as a mechanism to inhibit pancreatic cancer cell survival and proliferation and prolonged survival after tumor resection, which stressed that lumican plays a restrictive role in EGFR-expressing pancreatic cancer progression [18].